What we're reading, November 18, 2015: global drug spending is expected to grow 30% in 5 years; Robert M. Califf, MD, sits through mostly friendly senate confirmation hearing for FDA nomination; and moderate coffee consumption could reduce some risks of death.
Global Drug Spending Will Hit $1.3 Trillion in 2020
Sharp increases in drug spending it not an American phenomenon. According to an IMS Health report, global spending on medicines will rise between 3% and 6% annually over the next 5 years. The increase, to global spending of about $1.3 trillion in 2020, will be driven by expensive new drugs, price hikes, and aging populations. The spending increased would have been more except for a wave of patent expirations for expensive brand-name drugs during that time, the AP reported.
FDA Nominee Dr Califf Breezes Through Senate Committee
Robert M. Califf, MD, a cardiologist, clinical trial expert from Duke University, consultant to drug companies, and President Barack Obama’s nominee to lead the FDA came under scrutiny for his industry ties during his 2-hour hearing with the Senate Committee on Health, Education, Labor and Pensions, reported the New York Times. However, largely, the committee seemed to support his candidacy with the only exceptions being Elizabeth Warren (D-MA) and Bernie Sanders (I-VT), the presidential hopeful.
Moderate Coffee Consumption Reduces Risk of Death
Need a little coffee to get your day started? People who drink moderate amounts of coffee—between 1 and 5 cups a day—had a lower risk of mortality compared with people who don’t drink any coffee, according to a study in Circulation. Coffee consumption was associated with decreased risk of deaths due to cardiovascular disease, neurological diseases, and suicide. However, there was no associated decrease risk in mortality from cancer.
Males With Hemophilia A Report Physical, Mental Burdens of Disease Regardless of Severity
April 25th 2024Self-reported data from adult and pediatric males with hemophilia A show that burden of the disease persists regardless of severity, highlighting a need for improved prophylactic treatment.
Read More
What We’re Reading: FDA Approves UTI Antibiotic; Ozempic, Wegovy Price Investigation; US Births Fall
April 25th 2024The FDA recently approved an antibiotic for the treatment of urinary tract infections (UTIs) in women; a Senate committee recently launched an investigation into the prices of Novo Nordisk’s diabetes and weight loss drugs; US births fell last year, resuming a national slide after a previous increase during the pandemic.
Read More
HOPE-CAT Can Identify Maternal Cardiovascular Risk 2 Months Earlier Than Doctors, Study Says
April 25th 2024In a retrospective study, the machine learning tool was able to screen for potential risks of cardiovascular disease nearly 60 days before the patient's medical record showed any signs of a related condition or before they were officially diagnosed or treated for it.
Read More